ArticleIn vitro cellular & developmental biology. Animal2026

Ginsenoside F1 ameliorates nonalcoholic fatty liver disease by activating the AMPK/PGC-1α pathway and autophagy.

Wenjiao Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.